134 related articles for article (PubMed ID: 38771283)
1. In silico Screening of Food and Drug Administration-approved Compounds against Trehalose 2-sulfotransferase (Rv0295c) in Mycobacterium tuberculosis: Insights from Molecular Docking and Dynamics Simulations.
Sharma D; Gautam S; Srivastava N; Bisht D
Int J Mycobacteriol; 2024 Jan; 13(1):73-82. PubMed ID: 38771283
[TBL] [Abstract][Full Text] [Related]
2. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing.
Dwivedi M; Mukhopadhyay S; Yadav S; Dubey KD
Comput Biol Med; 2022 Jul; 146():105607. PubMed ID: 35617724
[TBL] [Abstract][Full Text] [Related]
3. In Silico Drug Repurposing Approach: Investigation of
Ngidi NTP; Machaba KE; Mhlongo NN
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163931
[No Abstract] [Full Text] [Related]
4. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
[TBL] [Abstract][Full Text] [Related]
5. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
6. Copper transporter protein (MctB) as a therapeutic target to elicit antimycobacterial activity against tuberculosis.
Dwivedi M; Jose S; Gupta M; Devi SS; Raj R; Kumar D
J Biomol Struct Dyn; 2024 Jul; 42(10):5334-5348. PubMed ID: 37340670
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.
Nyambo K; Tapfuma KI; Adu-Amankwaah F; Julius L; Baatjies L; Niang IS; Smith L; Govender KK; Ngxande M; Watson DJ; Wiesner L; Mavumengwana V
Sci Rep; 2024 Mar; 14(1):6794. PubMed ID: 38514663
[TBL] [Abstract][Full Text] [Related]
8. Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches.
Dash S; Rathi E; Kumar A; Chawla K; Kini SG
Sci Rep; 2024 May; 14(1):11315. PubMed ID: 38760437
[TBL] [Abstract][Full Text] [Related]
9. Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.
Khan MF; Ali A; Rehman HM; Noor Khan S; Hammad HM; Waseem M; Wu Y; Clark TG; Jabbar A
Sci Rep; 2024 May; 14(1):10904. PubMed ID: 38740859
[TBL] [Abstract][Full Text] [Related]
10. Insights into the Effects of Ligand Binding on Leucyl-tRNA Synthetase Inhibitors for Tuberculosis: In Silico Analysis and Isothermal Titration Calorimetry Validation.
Rehman ZU; Najmi A; Zoghebi K
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927114
[TBL] [Abstract][Full Text] [Related]
11. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
12. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
[TBL] [Abstract][Full Text] [Related]
13. In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis.
Isa MA; Majumdhar RS; Haider S
J Mol Model; 2018 May; 24(6):132. PubMed ID: 29752576
[TBL] [Abstract][Full Text] [Related]
14. A consensus reverse docking approach for identification of a competitive inhibitor of acetyltransferase enhanced intracellular survival protein from Mycobacterium tuberculosis.
Santos-Júnior PFDS; Batista VM; Nascimento IJDS; Nunes IC; Silva LR; Costa CACB; Freitas JD; Quintans-Júnior LJ; Araújo-Júnior JX; Freitas MEG; Zhan P; Green KD; Garneau-Tsodikova S; Mendonça-Júnior FJB; Rodrigues-Junior VS; Silva-Júnior EFD
Bioorg Med Chem; 2024 Jun; 108():117774. PubMed ID: 38833750
[TBL] [Abstract][Full Text] [Related]
15. Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations.
Sabe VT; Tolufashe GF; Ibeji CU; Maseko SB; Govender T; Maguire GEM; Lamichhane G; Honarparvar B; Kruger HG
J Mol Model; 2019 Oct; 25(11):328. PubMed ID: 31656981
[TBL] [Abstract][Full Text] [Related]
16. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
[TBL] [Abstract][Full Text] [Related]
17. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoinformatics-based identification of anti-bacterial catalase-peroxidase enzyme inhibitors.
Jangam CS; Bhowmick S; Chorge RD; Bharatrao LD; Patil PC; Chikhale RV; AlFaris NA; ALTamimi JZ; Wabaidur SM; Islam MA
Comput Biol Chem; 2019 Dec; 83():107136. PubMed ID: 31630014
[TBL] [Abstract][Full Text] [Related]
19. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.
Isa MA
Life Sci; 2020 Dec; 262():118466. PubMed ID: 32961233
[TBL] [Abstract][Full Text] [Related]
20. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
